Literature DB >> 21748667

HGF-induced DU145 cell scatter assay.

Sally T Fram1, Claire M Wells, Gareth E Jones.   

Abstract

Epithelial mesenchymal transition (EMT) is a multi-stage process whereby epithelial cells lose their cell:cell adhesions and acquire the capacity to migrate independently. It is a process that is important in normal development and is thought to be adopted by some invasive cancer cells. EMT requires modifications in cell shape and substratum adhesions and these events are dependent on the reorganisation of the actin cytoskeleton. Hepatocyte growth factor (HGF) is a mitogenic growth factor that is well known to induce such a conversion, termed "cell scattering", in Madin Darby canine kidney (MDCK) cells. Recently, we have developed an alternative model of cell scattering using the human prostate cancer cell line, DU145. Like MDCK cells, DU145 cells normally grow as tight colonies with firm cell:cell junctions, but they can be induced to 'scatter' upon HGF stimulation. Here, we describe the optimised protocol for conducting and analysing an HGF-induced DU145 scatter assay. This model is particularly useful for monitoring changes in actin cytoskeletal organisation and dynamics, cell:cell adhesions, and cell migration in human cells that respond to HGF stimulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21748667     DOI: 10.1007/978-1-61779-207-6_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Incomplete target neutralization by the anti-cancer antibody rilotumumab.

Authors:  Sameer A Greenall; Timothy E Adams; Terrance G Johns
Journal:  MAbs       Date:  2016       Impact factor: 5.857

2.  Hepatocyte growth factor increases the invasive potential of PC-3 human prostate cancer cells via an ERK/MAPK and Zeb-1 signaling pathway.

Authors:  Yili Han; Yong Luo; Yongxing Wang; Yatong Chen; Mingchuan Li; Yongguang Jiang
Journal:  Oncol Lett       Date:  2015-11-18       Impact factor: 2.967

3.  Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors.

Authors:  Bálint Szokol; Pál Gyulavári; Ibolya Kurkó; Ferenc Baska; Csaba Szántai-Kis; Zoltán Greff; Zoltán Orfi; István Peták; Kinga Pénzes; Robert Torka; Axel Ullrich; László Orfi; Tibor Vántus; György Kéri
Journal:  ACS Med Chem Lett       Date:  2014-01-30       Impact factor: 4.345

4.  E-cadherin plays an essential role in collective directional migration of large epithelial sheets.

Authors:  Li Li; Robert Hartley; Bjoern Reiss; Yaohui Sun; Jin Pu; Dan Wu; Francis Lin; Trung Hoang; Soichiro Yamada; Jianxin Jiang; Min Zhao
Journal:  Cell Mol Life Sci       Date:  2012-03-13       Impact factor: 9.261

5.  The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling.

Authors:  Bo Cen; Ying Xiong; Jin H Song; Sandeep Mahajan; Rachel DuPont; Kristen McEachern; Daniel J DeAngelo; Jorge E Cortes; Mark D Minden; Allen Ebens; Alice Mims; Amanda C LaRue; Andrew S Kraft
Journal:  Mol Cell Biol       Date:  2014-04-28       Impact factor: 4.272

6.  Dual modulation of Ras-Mnk and PI3K-AKT-mTOR pathways: A Novel c-FLIP inhibitory mechanism of 3-AWA mediated translational attenuation through dephosphorylation of eIF4E.

Authors:  Reyaz ur Rasool; Bilal Rah; Hina Amin; Debasis Nayak; Souneek Chakraborty; Abdul Rawoof; Mubashir Javed Mintoo; Khalid Yousuf; Debaraj Mukherjee; Lekha Dinesh Kumar; Dilip Manikaro Mondhe; Anindya Goswami
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379

7.  CCN3 promotes epithelial-mesenchymal transition in prostate cancer via FAK/Akt/HIF-1α-induced twist expression.

Authors:  Po-Chun Chen; Huai-Ching Tai; Tien-Huang Lin; Shih-Wei Wang; Chih-Yang Lin; Chia-Chia Chao; Hong-Jeng Yu; Yu-Chieh Tsai; Yu-Wei Lai; Chiao-Wen Lin; Chih-Hsin Tang
Journal:  Oncotarget       Date:  2017-08-10

8.  Collective cell migration: Implications for wound healing and cancer invasion.

Authors:  Li Li; Yong He; Min Zhao; Jianxin Jiang
Journal:  Burns Trauma       Date:  2013-06-18

9.  A novel role for atypical MAPK kinase ERK3 in regulating breast cancer cell morphology and migration.

Authors:  Rania Al-Mahdi; Nouf Babteen; Kiruthikah Thillai; Mark Holt; Bjarne Johansen; Hilde Ljones Wetting; Ole-Morten Seternes; Claire M Wells
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

10.  Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling.

Authors:  Benjamin Y Owusu; Namita Bansal; Phanindra K M Venukadasula; Larry J Ross; Troy E Messick; Sanjay Goel; Robert A Galemmo; Lidija Klampfer
Journal:  Oncotarget       Date:  2016-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.